SRI International to Develop Contraceptive Products for NICHD; Toufan Parman Comments
SRI International has received a $40 million contract to develop new contraceptive products for the Eunice Kennedy Shriver Institute of Child Health and Human Development. SRI Biosciences will perform the preclinical development and testing of potential therapeutic products in compliance with Investigational New Drug requirements, SRI said Tuesday. “We are pleased to continue supporting this […] More